These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30737087)

  • 1. Specific V-ATPase expression sub-classifies IDHwt lower-grade gliomas and impacts glioma growth in vivo.
    Terrasi A; Bertolini I; Martelli C; Gaudioso G; Di Cristofori A; Storaci AM; Formica M; Bosari S; Caroli M; Ottobrini L; Vaccari T; Vaira V
    EBioMedicine; 2019 Mar; 41():214-224. PubMed ID: 30737087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A GBM-like V-ATPase signature directs cell-cell tumor signaling and reprogramming via large oncosomes.
    Bertolini I; Terrasi A; Martelli C; Gaudioso G; Di Cristofori A; Storaci AM; Formica M; Braidotti P; Todoerti K; Ferrero S; Caroli M; Ottobrini L; Vaccari T; Vaira V
    EBioMedicine; 2019 Mar; 41():225-235. PubMed ID: 30737083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase Cγ1 (PLCG1) overexpression is associated with tumor growth and poor survival in IDH wild-type lower-grade gliomas in adult patients.
    Li T; Yang Z; Li H; Zhu J; Wang Y; Tang Q; Shi Z
    Lab Invest; 2022 Feb; 102(2):143-153. PubMed ID: 34697421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD40 Correlates Negatively with Overall and Progression-Free Survival of Low- and High-Grade Gliomas.
    Werner JM; Kuhl S; Ulrich K; Krischek B; Stavrinou P; Goldbrunner R; Timmer M
    World Neurosurg; 2019 Oct; 130():e17-e25. PubMed ID: 31125770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
    Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
    EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-cancer analysis of non-coding transcripts reveals the prognostic onco-lncRNA HOXA10-AS in gliomas.
    Isaev K; Jiang L; Wu S; Lee CA; Watters V; Fort V; Tsai R; Coutinho FJ; Hussein SMI; Zhang J; Wu J; Dirks PB; Schramek D; Reimand J
    Cell Rep; 2021 Oct; 37(3):109873. PubMed ID: 34686327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.
    Patil V; Mahalingam K
    Gene; 2018 Dec; 679():57-64. PubMed ID: 30077762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a five-gene signature deriving from the vacuolar ATPase (V-ATPase) sub-classifies gliomas and decides prognoses and immune microenvironment alterations.
    Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
    Cell Cycle; 2022 Jun; 21(12):1294-1315. PubMed ID: 35266851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subgroup characteristics of insular low-grade glioma based on clinical and molecular analysis of 42 cases.
    Tang C; Zhang ZY; Chen LC; Sun Z; Zhang Y; Qin Z; Yao Y; Zhou LF
    J Neurooncol; 2016 Feb; 126(3):499-507. PubMed ID: 26586262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients.
    Yu L; Xu J; Liu J; Zhang H; Sun C; Wang Q; Shi C; Zhou X; Hua D; Luo W; Bian X; Yu S
    Neuro Oncol; 2019 Jun; 21(6):742-754. PubMed ID: 30753603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IDH-1R132H mutation status in diffuse glioma patients: implications for classification.
    Wang PF; Liu N; Song HW; Yao K; Jiang T; Li SW; Yan CX
    Oncotarget; 2016 May; 7(21):31393-400. PubMed ID: 27120786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renal v-ATPase a4 subunit is expressed in specific subtypes of human gliomas.
    Gleize V; Boisselier B; Marie Y; Poëa-Guyon S; Sanson M; Morel N
    Glia; 2012 May; 60(6):1004-12. PubMed ID: 22460948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay Between V-ATPase G1 and Small EV-miRNAs Modulates ERK1/2 Activation in GBM Stem Cells and Nonneoplastic Milieu.
    Bertolini I; Storaci AM; Terrasi A; Cristofori AD; Locatelli M; Caroli M; Ferrero S; Altieri DC; Vaira V
    Mol Cancer Res; 2020 Nov; 18(11):1744-1754. PubMed ID: 32753475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional expression of V-ATPases in the plasma membrane of glial cells.
    Philippe JM; Dubois JM; Rouzaire-Dubois B; Cartron PF; Vallette F; Morel N
    Glia; 2002 Mar; 37(4):365-73. PubMed ID: 11870875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
    Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
    OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
    Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of ion channel genes in Chinese patients with gliomas based on mRNA expression profiling.
    Lu FF; Wang HY; He XZ; Liang TY; Wang W; Hu HM; Wu F; Liu YW; Zhang SZ
    J Neurooncol; 2017 Sep; 134(2):397-405. PubMed ID: 28752501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capillary morphogenesis protein 2 is a novel prognostic biomarker and plays oncogenic roles in glioma.
    Tan J; Liu M; Zhang JY; Yao YL; Wang YX; Lin Y; Song K; Tan J; Wu JR; Cui YH; Wang Y; Bian XW
    J Pathol; 2018 Jun; 245(2):160-171. PubMed ID: 29473166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
    Paul Y; Mondal B; Patil V; Somasundaram K
    Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas.
    Nakashima S; Sugita Y; Miyoshi H; Arakawa F; Muta H; Ishibashi Y; Niino D; Ohshima K; Terasaki M; Nakamura Y; Morioka M
    J Neurooncol; 2016 Mar; 127(1):23-32. PubMed ID: 26645886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.